Method: IHC
Detects Uroplakin II, a protein specific to the lining cells of the urinary bladder. Used to confirm bladder cancer origin when a tumour has spread to other sites.
Uroplakin II is one of the most specific markers for urothelial (bladder) cancer. Its presence in a tumour that has spread confirms bladder as the primary cancer site — directing treatment to bladder-cancer protocols.
No preparation needed — performed on biopsy or surgical tissue.
Price (MRP)
NPR 3,800
Order as a gift© 2026 Aashirbad Care. All rights reserved.